Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Gee

Showing results (321-330 of 383) with videos related to

Pageof 39
Sort By:
Breast Cancer Research : BCR|January 25, 2014
Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitroNicola J Jordan, Carol M Dutkowski, Denise Barrow, et al.
The Journal of Pathology|October 1, 2008
Overexpression of TFAP2C in invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survivalJ M W Gee, J J Eloranta, J C Ibbitt, et al.
Gastrointestinal Endoscopy|November 3, 2009
Feasibility of endoscopic transesophageal thoracic sympathectomy (with video)Brian G Turner, Denise W Gee, Sevdenur Cizginer, et al.
Gastrointestinal Endoscopy|February 4, 2011
A prospective, randomized trial of esophageal submucosal tunnel closure with a stent versus no closure to secure a transesophageal natural orifice transluminal endoscopic surgery access siteBrian G Turner, Min-Chan Kim, Denise W Gee, et al.
Endocrinology|February 15, 2003
Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cellsJanice M Knowlden, Iain R Hutcheson, Helen E Jones, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2007
Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulatorsHerman J Ng, Edward R Whittemore, Minhtam B Tran, et al.
Histopathology|September 13, 2011
A review of the biological and clinical characteristics of luminal-like oestrogen receptor-positive breast cancerHany O Habashy, Desmond G Powe, Tarek M Abdel-Fatah, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 30, 2005
Growth factor signalling networks in breast cancer and resistance to endocrine agents: new therapeutic strategiesR I Nicholson, I R Hutcheson, D Britton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Nonendocrine pathways and endocrine resistance: observations with antiestrogens and signal transduction inhibitors in combinationRobert I Nicholson, Iain R Hutcheson, Janice M Knowlden, et al.
Endocrine-Related Cancer|December 23, 2004
Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cellsH E Jones, L Goddard, J M W Gee, et al.
Pageof 39

Showing results (321-330 of 383) with videos related to

Sort By:
Pageof 39
Breast Cancer Research : BCR|January 25, 2014
Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitroNicola J Jordan, Carol M Dutkowski, Denise Barrow, et al.
The Journal of Pathology|October 1, 2008
Overexpression of TFAP2C in invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survivalJ M W Gee, J J Eloranta, J C Ibbitt, et al.
Gastrointestinal Endoscopy|November 3, 2009
Feasibility of endoscopic transesophageal thoracic sympathectomy (with video)Brian G Turner, Denise W Gee, Sevdenur Cizginer, et al.
Gastrointestinal Endoscopy|February 4, 2011
A prospective, randomized trial of esophageal submucosal tunnel closure with a stent versus no closure to secure a transesophageal natural orifice transluminal endoscopic surgery access siteBrian G Turner, Min-Chan Kim, Denise W Gee, et al.
Endocrinology|February 15, 2003
Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cellsJanice M Knowlden, Iain R Hutcheson, Helen E Jones, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2007
Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulatorsHerman J Ng, Edward R Whittemore, Minhtam B Tran, et al.
Histopathology|September 13, 2011
A review of the biological and clinical characteristics of luminal-like oestrogen receptor-positive breast cancerHany O Habashy, Desmond G Powe, Tarek M Abdel-Fatah, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 30, 2005
Growth factor signalling networks in breast cancer and resistance to endocrine agents: new therapeutic strategiesR I Nicholson, I R Hutcheson, D Britton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Nonendocrine pathways and endocrine resistance: observations with antiestrogens and signal transduction inhibitors in combinationRobert I Nicholson, Iain R Hutcheson, Janice M Knowlden, et al.
Endocrine-Related Cancer|December 23, 2004
Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cellsH E Jones, L Goddard, J M W Gee, et al.
Pageof 39